Global Medical Polymers

Medical Polymers Comprehensive Study by Type (Medical Fibers & Resins (Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others), Medical Elastomers (Styrene Block Copolymer (SBC), Rubber Latex, Others), Biodegradable Medical Plastics), Application (Devices (Surgical Instruments, Diagnostic Equipment, Others), Implant (orthopedic implant, Electronic Implant, Dental Implant), Medical Packaging) Players and Region - Global Market Outlook to 2026

Medical Polymers Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Growing research and development for developing alternatives to traditional material such as metal and polymer in medical practices driving the demand for medical polymer market. In addition, the cost of metal polymers is low compared to polymers and metals boosting the adoption of medical polymers in the healthcare sector. Moreover, increasing adoption of the medical polymers for pharmaceutical devices expected to drive the medical polymers market throughout the forecast period.This growth is primarily driven by Increasing Adoption of Medical Polymers Due To Low Prices and Growing Geriatric Population.

Globally, a noticeable market trend is evident Innovation and Customization of Medical Polymers . Major Players, such as BASF SE (Germany), Bayer Material Science AG (Germany), Celanese Corporation (United States), DSM N.V. (Netherland), Eastman Chemical (United States), Evonik Industries AG (Germany), The Dow Chemical Company (United States), Du Pont (United States), Solvay (Belgium), ExxonMobil (United States), Victrex (United Kingdom) and Raumedic AG (Germany) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Market Drivers
  • Increasing Adoption of Medical Polymers Due To Low Prices
  • Growing Geriatric Population

Market Trend
  • Innovation and Customization of Medical Polymers
  • Government Initiative for Performing Clinical Trials

Restraints
  • Government Control over Healthcare Costs
  • Stringent Approval Process and Variations in Regulations across Globe

Opportunities
Growing Healthcare Investments in Emerging Economies and Increasing Demand for Medical Implants and Devices
Challenges
Waste Management Concerns and Lack of Skilled Healthcare Professionals

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Medical Polymers Study Sheds Light on
— The Medical Polymers Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Medical Polymers industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Medical Polymers industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Medical Fibers & Resins [Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others]
  • Medical Elastomers [Styrene Block Copolymer (SBC), Rubber Latex, Others]
  • Biodegradable Medical Plastics
By Application
  • Devices [Surgical Instruments, Diagnostic Equipment, Others]
  • Implant [orthopedic implant, Electronic Implant, Dental Implant]
  • Medical Packaging
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Adoption of Medical Polymers Due To Low Prices
      • 3.2.2. Growing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Waste Management Concerns
      • 3.3.2. Lack of Skilled Healthcare Professionals
    • 3.4. Market Trends
      • 3.4.1. Innovation and Customization of Medical Polymers
      • 3.4.2. Government Initiative for Performing Clinical Trials
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Polymers, by Type, Application and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Medical Polymers (Value)
      • 5.2.1. Global Medical Polymers by: Type (Value)
        • 5.2.1.1. Medical Fibers & Resins [Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others]
        • 5.2.1.2. Medical Elastomers [Styrene Block Copolymer (SBC), Rubber Latex, Others]
        • 5.2.1.3. Biodegradable Medical Plastics
      • 5.2.2. Global Medical Polymers by: Application (Value)
        • 5.2.2.1. Devices [Surgical Instruments, Diagnostic Equipment, Others]
        • 5.2.2.2. Implant [orthopedic implant, Electronic Implant, Dental Implant]
        • 5.2.2.3. Medical Packaging
      • 5.2.3. Global Medical Polymers Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Medical Polymers: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. BASF SE (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bayer Material Science AG (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Celanese Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DSM N.V. (Netherland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Eastman Chemical (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Evonik Industries AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. The Dow Chemical Company (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Du Pont (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Solvay (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ExxonMobil (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Victrex (United Kingdom)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Raumedic AG (Germany)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Medical Polymers Sale, by Type, Application and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Medical Polymers (Value)
      • 7.2.1. Global Medical Polymers by: Type (Value)
        • 7.2.1.1. Medical Fibers & Resins [Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others]
        • 7.2.1.2. Medical Elastomers [Styrene Block Copolymer (SBC), Rubber Latex, Others]
        • 7.2.1.3. Biodegradable Medical Plastics
      • 7.2.2. Global Medical Polymers by: Application (Value)
        • 7.2.2.1. Devices [Surgical Instruments, Diagnostic Equipment, Others]
        • 7.2.2.2. Implant [orthopedic implant, Electronic Implant, Dental Implant]
        • 7.2.2.3. Medical Packaging
      • 7.2.3. Global Medical Polymers Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Polymers: by Type(USD Million)
  • Table 2. Medical Polymers Medical Fibers & Resins [Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others] , by Region USD Million (2015-2020)
  • Table 3. Medical Polymers Medical Elastomers [Styrene Block Copolymer (SBC), Rubber Latex, Others] , by Region USD Million (2015-2020)
  • Table 4. Medical Polymers Biodegradable Medical Plastics , by Region USD Million (2015-2020)
  • Table 5. Medical Polymers: by Application(USD Million)
  • Table 6. Medical Polymers Devices [Surgical Instruments, Diagnostic Equipment, Others] , by Region USD Million (2015-2020)
  • Table 7. Medical Polymers Implant [orthopedic implant, Electronic Implant, Dental Implant] , by Region USD Million (2015-2020)
  • Table 8. Medical Polymers Medical Packaging , by Region USD Million (2015-2020)
  • Table 9. South America Medical Polymers, by Country USD Million (2015-2020)
  • Table 10. South America Medical Polymers, by Type USD Million (2015-2020)
  • Table 11. South America Medical Polymers, by Application USD Million (2015-2020)
  • Table 12. Brazil Medical Polymers, by Type USD Million (2015-2020)
  • Table 13. Brazil Medical Polymers, by Application USD Million (2015-2020)
  • Table 14. Argentina Medical Polymers, by Type USD Million (2015-2020)
  • Table 15. Argentina Medical Polymers, by Application USD Million (2015-2020)
  • Table 16. Rest of South America Medical Polymers, by Type USD Million (2015-2020)
  • Table 17. Rest of South America Medical Polymers, by Application USD Million (2015-2020)
  • Table 18. Asia Pacific Medical Polymers, by Country USD Million (2015-2020)
  • Table 19. Asia Pacific Medical Polymers, by Type USD Million (2015-2020)
  • Table 20. Asia Pacific Medical Polymers, by Application USD Million (2015-2020)
  • Table 21. China Medical Polymers, by Type USD Million (2015-2020)
  • Table 22. China Medical Polymers, by Application USD Million (2015-2020)
  • Table 23. Japan Medical Polymers, by Type USD Million (2015-2020)
  • Table 24. Japan Medical Polymers, by Application USD Million (2015-2020)
  • Table 25. India Medical Polymers, by Type USD Million (2015-2020)
  • Table 26. India Medical Polymers, by Application USD Million (2015-2020)
  • Table 27. South Korea Medical Polymers, by Type USD Million (2015-2020)
  • Table 28. South Korea Medical Polymers, by Application USD Million (2015-2020)
  • Table 29. Taiwan Medical Polymers, by Type USD Million (2015-2020)
  • Table 30. Taiwan Medical Polymers, by Application USD Million (2015-2020)
  • Table 31. Australia Medical Polymers, by Type USD Million (2015-2020)
  • Table 32. Australia Medical Polymers, by Application USD Million (2015-2020)
  • Table 33. Rest of Asia-Pacific Medical Polymers, by Type USD Million (2015-2020)
  • Table 34. Rest of Asia-Pacific Medical Polymers, by Application USD Million (2015-2020)
  • Table 35. Europe Medical Polymers, by Country USD Million (2015-2020)
  • Table 36. Europe Medical Polymers, by Type USD Million (2015-2020)
  • Table 37. Europe Medical Polymers, by Application USD Million (2015-2020)
  • Table 38. Germany Medical Polymers, by Type USD Million (2015-2020)
  • Table 39. Germany Medical Polymers, by Application USD Million (2015-2020)
  • Table 40. France Medical Polymers, by Type USD Million (2015-2020)
  • Table 41. France Medical Polymers, by Application USD Million (2015-2020)
  • Table 42. Italy Medical Polymers, by Type USD Million (2015-2020)
  • Table 43. Italy Medical Polymers, by Application USD Million (2015-2020)
  • Table 44. United Kingdom Medical Polymers, by Type USD Million (2015-2020)
  • Table 45. United Kingdom Medical Polymers, by Application USD Million (2015-2020)
  • Table 46. Netherlands Medical Polymers, by Type USD Million (2015-2020)
  • Table 47. Netherlands Medical Polymers, by Application USD Million (2015-2020)
  • Table 48. Rest of Europe Medical Polymers, by Type USD Million (2015-2020)
  • Table 49. Rest of Europe Medical Polymers, by Application USD Million (2015-2020)
  • Table 50. MEA Medical Polymers, by Country USD Million (2015-2020)
  • Table 51. MEA Medical Polymers, by Type USD Million (2015-2020)
  • Table 52. MEA Medical Polymers, by Application USD Million (2015-2020)
  • Table 53. Middle East Medical Polymers, by Type USD Million (2015-2020)
  • Table 54. Middle East Medical Polymers, by Application USD Million (2015-2020)
  • Table 55. Africa Medical Polymers, by Type USD Million (2015-2020)
  • Table 56. Africa Medical Polymers, by Application USD Million (2015-2020)
  • Table 57. North America Medical Polymers, by Country USD Million (2015-2020)
  • Table 58. North America Medical Polymers, by Type USD Million (2015-2020)
  • Table 59. North America Medical Polymers, by Application USD Million (2015-2020)
  • Table 60. United States Medical Polymers, by Type USD Million (2015-2020)
  • Table 61. United States Medical Polymers, by Application USD Million (2015-2020)
  • Table 62. Canada Medical Polymers, by Type USD Million (2015-2020)
  • Table 63. Canada Medical Polymers, by Application USD Million (2015-2020)
  • Table 64. Mexico Medical Polymers, by Type USD Million (2015-2020)
  • Table 65. Mexico Medical Polymers, by Application USD Million (2015-2020)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Medical Polymers: by Type(USD Million)
  • Table 79. Medical Polymers Medical Fibers & Resins [Polyvinyl chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), others] , by Region USD Million (2021-2026)
  • Table 80. Medical Polymers Medical Elastomers [Styrene Block Copolymer (SBC), Rubber Latex, Others] , by Region USD Million (2021-2026)
  • Table 81. Medical Polymers Biodegradable Medical Plastics , by Region USD Million (2021-2026)
  • Table 82. Medical Polymers: by Application(USD Million)
  • Table 83. Medical Polymers Devices [Surgical Instruments, Diagnostic Equipment, Others] , by Region USD Million (2021-2026)
  • Table 84. Medical Polymers Implant [orthopedic implant, Electronic Implant, Dental Implant] , by Region USD Million (2021-2026)
  • Table 85. Medical Polymers Medical Packaging , by Region USD Million (2021-2026)
  • Table 86. South America Medical Polymers, by Country USD Million (2021-2026)
  • Table 87. South America Medical Polymers, by Type USD Million (2021-2026)
  • Table 88. South America Medical Polymers, by Application USD Million (2021-2026)
  • Table 89. Brazil Medical Polymers, by Type USD Million (2021-2026)
  • Table 90. Brazil Medical Polymers, by Application USD Million (2021-2026)
  • Table 91. Argentina Medical Polymers, by Type USD Million (2021-2026)
  • Table 92. Argentina Medical Polymers, by Application USD Million (2021-2026)
  • Table 93. Rest of South America Medical Polymers, by Type USD Million (2021-2026)
  • Table 94. Rest of South America Medical Polymers, by Application USD Million (2021-2026)
  • Table 95. Asia Pacific Medical Polymers, by Country USD Million (2021-2026)
  • Table 96. Asia Pacific Medical Polymers, by Type USD Million (2021-2026)
  • Table 97. Asia Pacific Medical Polymers, by Application USD Million (2021-2026)
  • Table 98. China Medical Polymers, by Type USD Million (2021-2026)
  • Table 99. China Medical Polymers, by Application USD Million (2021-2026)
  • Table 100. Japan Medical Polymers, by Type USD Million (2021-2026)
  • Table 101. Japan Medical Polymers, by Application USD Million (2021-2026)
  • Table 102. India Medical Polymers, by Type USD Million (2021-2026)
  • Table 103. India Medical Polymers, by Application USD Million (2021-2026)
  • Table 104. South Korea Medical Polymers, by Type USD Million (2021-2026)
  • Table 105. South Korea Medical Polymers, by Application USD Million (2021-2026)
  • Table 106. Taiwan Medical Polymers, by Type USD Million (2021-2026)
  • Table 107. Taiwan Medical Polymers, by Application USD Million (2021-2026)
  • Table 108. Australia Medical Polymers, by Type USD Million (2021-2026)
  • Table 109. Australia Medical Polymers, by Application USD Million (2021-2026)
  • Table 110. Rest of Asia-Pacific Medical Polymers, by Type USD Million (2021-2026)
  • Table 111. Rest of Asia-Pacific Medical Polymers, by Application USD Million (2021-2026)
  • Table 112. Europe Medical Polymers, by Country USD Million (2021-2026)
  • Table 113. Europe Medical Polymers, by Type USD Million (2021-2026)
  • Table 114. Europe Medical Polymers, by Application USD Million (2021-2026)
  • Table 115. Germany Medical Polymers, by Type USD Million (2021-2026)
  • Table 116. Germany Medical Polymers, by Application USD Million (2021-2026)
  • Table 117. France Medical Polymers, by Type USD Million (2021-2026)
  • Table 118. France Medical Polymers, by Application USD Million (2021-2026)
  • Table 119. Italy Medical Polymers, by Type USD Million (2021-2026)
  • Table 120. Italy Medical Polymers, by Application USD Million (2021-2026)
  • Table 121. United Kingdom Medical Polymers, by Type USD Million (2021-2026)
  • Table 122. United Kingdom Medical Polymers, by Application USD Million (2021-2026)
  • Table 123. Netherlands Medical Polymers, by Type USD Million (2021-2026)
  • Table 124. Netherlands Medical Polymers, by Application USD Million (2021-2026)
  • Table 125. Rest of Europe Medical Polymers, by Type USD Million (2021-2026)
  • Table 126. Rest of Europe Medical Polymers, by Application USD Million (2021-2026)
  • Table 127. MEA Medical Polymers, by Country USD Million (2021-2026)
  • Table 128. MEA Medical Polymers, by Type USD Million (2021-2026)
  • Table 129. MEA Medical Polymers, by Application USD Million (2021-2026)
  • Table 130. Middle East Medical Polymers, by Type USD Million (2021-2026)
  • Table 131. Middle East Medical Polymers, by Application USD Million (2021-2026)
  • Table 132. Africa Medical Polymers, by Type USD Million (2021-2026)
  • Table 133. Africa Medical Polymers, by Application USD Million (2021-2026)
  • Table 134. North America Medical Polymers, by Country USD Million (2021-2026)
  • Table 135. North America Medical Polymers, by Type USD Million (2021-2026)
  • Table 136. North America Medical Polymers, by Application USD Million (2021-2026)
  • Table 137. United States Medical Polymers, by Type USD Million (2021-2026)
  • Table 138. United States Medical Polymers, by Application USD Million (2021-2026)
  • Table 139. Canada Medical Polymers, by Type USD Million (2021-2026)
  • Table 140. Canada Medical Polymers, by Application USD Million (2021-2026)
  • Table 141. Mexico Medical Polymers, by Type USD Million (2021-2026)
  • Table 142. Mexico Medical Polymers, by Application USD Million (2021-2026)
  • Table 143. Research Programs/Design for This Report
  • Table 144. Key Data Information from Secondary Sources
  • Table 145. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Polymers: by Type USD Million (2015-2020)
  • Figure 5. Global Medical Polymers: by Application USD Million (2015-2020)
  • Figure 6. South America Medical Polymers Share (%), by Country
  • Figure 7. Asia Pacific Medical Polymers Share (%), by Country
  • Figure 8. Europe Medical Polymers Share (%), by Country
  • Figure 9. MEA Medical Polymers Share (%), by Country
  • Figure 10. North America Medical Polymers Share (%), by Country
  • Figure 11. Global Medical Polymers share by Players 2020 (%)
  • Figure 12. Global Medical Polymers share by Players (Top 3) 2020(%)
  • Figure 13. Global Medical Polymers share by Players (Top 5) 2020(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. BASF SE (Germany) Revenue, Net Income and Gross profit
  • Figure 16. BASF SE (Germany) Revenue: by Geography 2020
  • Figure 17. Bayer Material Science AG (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Bayer Material Science AG (Germany) Revenue: by Geography 2020
  • Figure 19. Celanese Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Celanese Corporation (United States) Revenue: by Geography 2020
  • Figure 21. DSM N.V. (Netherland) Revenue, Net Income and Gross profit
  • Figure 22. DSM N.V. (Netherland) Revenue: by Geography 2020
  • Figure 23. Eastman Chemical (United States) Revenue, Net Income and Gross profit
  • Figure 24. Eastman Chemical (United States) Revenue: by Geography 2020
  • Figure 25. Evonik Industries AG (Germany) Revenue, Net Income and Gross profit
  • Figure 26. Evonik Industries AG (Germany) Revenue: by Geography 2020
  • Figure 27. The Dow Chemical Company (United States) Revenue, Net Income and Gross profit
  • Figure 28. The Dow Chemical Company (United States) Revenue: by Geography 2020
  • Figure 29. Du Pont (United States) Revenue, Net Income and Gross profit
  • Figure 30. Du Pont (United States) Revenue: by Geography 2020
  • Figure 31. Solvay (Belgium) Revenue, Net Income and Gross profit
  • Figure 32. Solvay (Belgium) Revenue: by Geography 2020
  • Figure 33. ExxonMobil (United States) Revenue, Net Income and Gross profit
  • Figure 34. ExxonMobil (United States) Revenue: by Geography 2020
  • Figure 35. Victrex (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Victrex (United Kingdom) Revenue: by Geography 2020
  • Figure 37. Raumedic AG (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Raumedic AG (Germany) Revenue: by Geography 2020
  • Figure 39. Global Medical Polymers: by Type USD Million (2021-2026)
  • Figure 40. Global Medical Polymers: by Application USD Million (2021-2026)
  • Figure 41. South America Medical Polymers Share (%), by Country
  • Figure 42. Asia Pacific Medical Polymers Share (%), by Country
  • Figure 43. Europe Medical Polymers Share (%), by Country
  • Figure 44. MEA Medical Polymers Share (%), by Country
  • Figure 45. North America Medical Polymers Share (%), by Country
List of companies from research coverage that are profiled in the study
  • BASF SE (Germany)
  • Bayer Material Science AG (Germany)
  • Celanese Corporation (United States)
  • DSM N.V. (Netherland)
  • Eastman Chemical (United States)
  • Evonik Industries AG (Germany)
  • The Dow Chemical Company (United States)
  • Du Pont (United States)
  • Solvay (Belgium)
  • ExxonMobil (United States)
  • Victrex (United Kingdom)
  • Raumedic AG (Germany)
Select User Access Type

Key Highlights of Report


Sep 2021 237 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Medical Polymers Quantitative research analysis
Global Medical Polymers Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Medical Polymers Market are BASF SE (Germany), Bayer Material Science AG (Germany), Celanese Corporation (United States), DSM N.V. (Netherland), Eastman Chemical (United States), Evonik Industries AG (Germany), The Dow Chemical Company (United States), Du Pont (United States), Solvay (Belgium), ExxonMobil (United States), Victrex (United Kingdom) and Raumedic AG (Germany) etc.
Growing research and development for developing alternatives to traditional material such as metal and polymer in medical practices driving the demand for medical polymer market. In addition, the cost of metal polymers is low compared to polymers and metals boosting the adoption of medical polymers in the healthcare sector. Moreover, increasing adoption of the medical polymers for pharmaceutical devices expected to drive the medical polymers market throughout the forecast period.

Know More About Global Medical Polymers Report?

Have a Query? Click Here

Other Related Reports

Nano Biosensors - Comprehensive Study by Application (Biological Application {DNA Sensors, Immunosensors, Cell based Sensor, Point of care Sensors, bacteria sensors, others}, Environmental Applicatio...
$ 4000
Bioresorbable Polymers Comprehensive Study by Type (Polylactic acid, Polyglycolic acid, Polycaprolactone, Polysaccharides, Proteins, Others), Application (Drug Delivery, Orthopedics, Others), Origin ...
$ 3450
Marine Enzymes Comprehensive Study by Type (Amylases, Lipases, DNases, Other), Application (Food and Beverages, Pharmaceutical, Neutraceutical, Cosmetic Industry, Other), Source (Microorganisms {Extr...
$ 3500
Integrin Beta 1 Comprehensive Study by Type (AXT-108, C-16Y, CLT-28643, SAL-021, Others), Application (Genetic Disorders, Dermatology, Cardiovascular, Others) Players and Region - Global Market Outlo...
$ 3500
Digestive Enzyme Supplements Comprehensive Study by Type (Bromelain, Lipase, Papain, Lactase), Application (Infant Nutrition, Medical Nutrition, Sports Nutrition, Other), Origin (Animal, Plant, Micro...
$ 3650
Optogenetics Comprehensive Study by Application (Retinal disease treatment, Neuroscience, Cardioversion, Pacing, Others), Actuators (Halorhodospin, Channelrhodospin, Archaerhodospin), Sensor Type (Ge...
$ 3800